Differentiation of multipotential hematopoietic cells into lineage-committed precursors involves the selection and maintenance of appropriate programs of gene expression, regulated by specific transcription factors. Using human K562 erythroleukemia cells capable of differentiating along erythroid and megakaryocytic lineages, we explore the differentiation-related role of heat shock transcription factor 2 (HSF2), which belongs to a family of transcription factors generally known to regulate heat shock gene expression. We demonstrate that enhanced HSF2 expression and the acquisition of HSF2 DNA binding activity are strictly specific for erythroid characteristics of K562 cells. Our results reveal a multistep regulatory process of HSF2 gene expression. In K562 cells undergoing hemin-mediated erythroid differentiation, the increase in HSF2 protein levels is preceded by transcriptional induction of the HSF2 gene, accompanied by increased HSF2 mRNA stability. In contrast, during megakaryocytic differentiation induced by the phorbol ester TPA, expression of HSF2 is rapidly down-regulated, leading to a complete loss of the HSF2 protein.
Differentiation of lineage-committed precursors from multipotential hematopoietic cells involves the selection and maintenance of appropriate programs of gene expression. These programs presumably arise from changes in the functional balance of cellular transcription factors, resulting in the formation of stable active transcription complexes at the regulatory elements of differentiation lineage-specific gene loci (for review, see refs 1, 2). Differentiation lineagerestricted transcription factors are thus good candidates for mediating the various signals in immature cells to establish or maintain differentiation lineagespecific gene expression. Therefore, it is essential to study the expression, complex formation, and chromatin accessibility of these specific transcription factors to understand the mechanisms underlying the complex processes of cell differentiation.
The human K562 erythroleukemia cell line is a multipotent hematopoietic precursor cell line derived from a patient with chronic myeloid leukemia in blast crisis (3) . K562 cells can be induced to differentiate along several lineages, thus providing a model system to study gene expression during hematopoiesis. The K562 cell line has been used extensively in studies of hemin-induced erythroid differentiation (4 -6) . Treatment of K562 cells with hemin, the synthetic form of heme, induces the synthesis of red cell-specific proteins, such as globin polypeptides, as a result of transcriptional activation of the embryonic ␣-and ␤-like globin genes, and ⑀, respectively, as well as the fetal ␥-globin and adult ␣-globin genes (6) . Hemin treatment does not, however, lead to terminal differentiation of K562 cells, thereby dissociating increases in intracellular hemoglobin content from other events considered central to erythroid differentiation (5) . On the other hand, treatment of K562 cells with the tumor promoter 12-O-tetradecanoyl-phorbol 13-acetate (TPA) 2 shifts these cells toward megakaryocytic pathway of differentiation, leading to loss of their erythroid properties and to acquisition of several megakaryoblastoid characteristics, including synthesis and secretion of platelet-derived growth factor (PDGF) polypeptides as well as synthesis and surface expression of glycoprotein IIIa (for review, see ref 7) . TPA is known to exert its effects on various cellular processes, such as growth and differentiation, through activation of protein kinase C (8) . For example, TPA-induced megakaryocytic differentiation of the human HEL erythroleukemia cells has been shown to be mediated by protein kinase C (9) . Transcriptional activation of heat shock genes, which ultimately leads to increased synthesis of heat shock proteins (Hsp's), is regulated by a family of transcription factors called heat shock factors (HSFs) that respond to external stimuli, such as elevated temperatures and diverse physiological and environmental stressors (for review, see refs 10, 11) . In yeast and Drosophila, only one HSF-encoding gene has been identified (12, 13) , whereas in vertebrates several members of the HSF family (HSF1-4) have been cloned (14 -18) . In mammalian cells, HSF1 mediates the ubiquitous response to stress stimuli, whereas HSF2 is regulated by distinct signaling mechanisms. HSF2 is abundantly expressed and constitutively active in mouse embryonal carcinoma cells, at the blastocyst stage during mouse embryogenesis, and during spermatogenesis, suggesting a role for HSF2 as a developmental regulator (19 -23) . In addition, HSF2 binds to a specific DNA binding sequence (heat shock element, HSE) in the hsp70 gene promoter, leading to abundant expression of Hsp70 protein during hemin-mediated erythroid differentiation of K562 cells (24 -27) . During embryogenesis, however, the pattern of HSF2 DNA binding activity does not coincide with the expression profile of any of the known Hsp's (22) . The expression of thioredoxin (TRX) is induced in K562 cells in response to hemin in an HSF2-dependent manner (28) , providing evidence that HSF2 might regulate genes other than the known heat shock genes. Recently, the roles of distinct HSFs have been proposed to overlap depending on stimulatory signals. For example, HSF2 activation and consequent transcriptional induction of heat shock genes have been indicated in cells where the ubiquitin-proteasome pathway is inhibited (29) . Moreover, mutated yeast cells carrying a lethal HSF deletion can be rescued by human HSF2, but not by HSF1 (30) .
More complexity to the regulatory functions of HSF2 is added by the finding that HSF2 exists as two alternatively spliced isoforms, HSF2-␣ and HSF2-␤ (31, 32) . According to our recent results, HSF2-␣ is the predominantly expressed isoform in K562 cells (27) . A molar excess of HSF2-␣ is required for the hemin-mediated activation of HSF2 since overexpression of the HSF2-␤ isoform inhibits HSF2 activity, hemin-induced transcription of heat shock genes, and erythroid differentiation of K562 cells (27) . In this study, we have analyzed the expression of human HSF2 in K562 cells induced to differentiate by hemin or TPA along the erythroid or the megakaryocytic lineage, respectively. Our results reveal that the expression of HSF2 is strictly and specifically regulated in a lineage-restricted manner, i.e., hemin enhances and TPA down-regulates HSF2 expression in K562 cells, suggesting that HSF2 might be an important transcriptional regulator involved in erythroid differentiation.
MATERIALS AND METHODS
Cell culture and experimental treatments K562 (erythroleukemia) and Molt-4 (T-lymphoblastic leukemia) cells were maintained in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS) and antibiotics (penicillin and streptomycin) in a humidified 5% CO 2 atmosphere at 37°C. Raji (Burkitt's lymphoma) cells were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% FCS and antibiotics. HeLa (cervical carcinoma) cells were grown as a monolayer in DMEM containing 5% FCS and antibiotics. K562 cells stably overexpressing HSF2-␣ and HSF2-␤ isoforms (2␣-C7 and 2␤-D5, respectively; ref 27) were maintained in RPMI 1640 medium containing G418 (500 g/ml; Life Technologies, Inc., Paisley, U.K.). For experimental treatments, cells were seeded at 5 ϫ 10 6 cells per 10 cm-diameter plate (HSF2-␣-and HSF2-␤-overexpressing cells were plated in RPMI 1640 medium without G418). Hemin (Aldrich, Milwaukee, Wis.) was added to a final concentration of 30 M, TPA (Sigma, St. Louis, Mo.) to 10 nM, and actinomycin D (Sigma) to 6.4 g/ml; cells were incubated at 37°C for the time periods indicated. Heat shock was performed at 42°C in a waterbath.
Gel mobility shift analysis
Whole-cell extracts were prepared from experimentally treated cells, as described previously (33) , and incubated (12 g protein) with a 32 P-labeled oligonucleotide representing the proximal HSE of the human hsp70 promoter. The protein-DNA complexes were analyzed on a native 4% polyacrylamide gel as described previously (33) . The signal intensities of the protein-DNA complexes were quantitated using a phosphorimaging scanner (Bio-Rad, Hercules, Calif.). For antibody supershift experiments to analyze HSF1 and HSF2 composition in the HSE binding complex in K562 cells treated with 30 M hemin for 18 h or 10 nM TPA for 24 h, dilutions (1:10, 1:50, and 1:100) of antisera against mouse HSF1 and mouse HSF2 (␣mHSF1 and ␣mHSF2, respectively; a kind gift from Dr. Richard Morimoto; ref 34) were added to whole-cell extracts and incubated at 25°C for 15 min prior to gel mobility shift analysis. For the competition experiment, the binding reaction mixture contained 0.1 ng of the labeled HSE oligonucleotide and a 50-, 100-, or 200-fold molar excess of the unlabeled HSE oligonucleotide or a 100-fold molar excess of an unspecific oligonucleotide.
(SDS-PAGE) and transferred to nitrocellulose filter (Protran Nitrocellulose; Schleicher & Schuell, Keene, N.H.) using a Bio-Rad semidry transfer apparatus. HSF2 was detected by a polyclonal antibody specific to mouse HSF2 (34), the inducible form of Hsp70 by 4g4 (Affinity Bioreagents, Inc., Neshanic Station, N.J.), the constitutively expressed Hsc70 by SPA-815 (StressGen, Victoria, B.C., Canada), and fetal ␥-globin by PBF-R (Isolab, Akron, Ohio). Horseradish peroxidaseconjugated secondary antibodies were purchased from Promega (Madison, Wis.) and Amersham (Little Chalfont, U.K.). The blots were developed with an enhanced chemiluminescence method (Amersham).
Northern blot analysis
Poly(A) mRNA was isolated from the treated cells using a poly(A) mRNA purification kit (Pharmacia, Piscataway, N.J.). RNA was separated on a 1% agarose-formaldehyde gel, transferred to nylon filter (Hybond-N; Amersham), and hybridized at 65°C with a [␣- 
Nuclear run-on analysis
Nuclear run-on transcription reactions were performed with nuclei isolated from hemin-or heat shock-treated cells in the presence of 100 Ci of [␣-
32 P]dUTP (3000 Ci/mmol; Amersham) as described previously (38) . Radiolabeled RNA was hybridized to nitrocellulose immobilized 931 bp HindIII/PstI cDNA insert coding for human HSF2 (16) 
RESULTS

Activation and expression of HSF2 are specific for the erythroid properties of K562 cells
HSF2 DNA binding is induced in K562 cells committed to differentiate along the erythroid lineage by hemin (26) . The differentiation lineage specificity of HSF2 expression has, however, remained unknown. Therefore, we examined the activation and expression of HSF2 during TPA-induced differentiation of K562 cells toward the megakaryocytic pathway. First, we confirmed the ability of K562 cells to differentiate along the erythroid and megakaryocytic lineages by hemin and TPA by analyzing the expression of specific markers, i.e., the fetal ␥-globin and PDGF polypeptide, respectively. In accordance with earlier studies (5, 40) , accumulation of the fetal ␥-globin polypeptide was markedly increased after 48 h of hemin treatment as compared with untreated cells, whereas during the corresponding treatment with TPA, the ␥-globin polypeptide could not be detected (Fig. 1A, left panel) . Abundant expression of PDGF-B mRNA was observed by 24 -48 h of TPA incubation, but not on hemin treatment (Fig. 1A,  right panel) .
As shown in the left panel of Fig. 1B , HSF-HSE complex formation was induced by 16 h treatment with hemin, but not by TPA. Consistent with our earlier results, HSF2 was primarily activated in hemin-treated K562 cells, as shown by antibody supershift assay using specific antisera against mouse HSF1 and HSF2 ( Furthermore, HSF2 activation appears to be irreversible, as the already activated HSF2 could not be inactivated by TPA. After several hours of exposure to TPA, a faster migrating, smaller molecular weight DNA binding complex of unknown origin was observed (asterisks in Fig. 1B ). It appears, however, that this DNA binding complex did not contain HSF2, since neither the specific antisera against mouse HSF1 or HSF2 nor an excess of nonradiolabeled HSE oligonucleotide displaced the corresponding band (Fig. 1B, right panel) .
To analyze the effects of hemin and TPA on HSF2 expression, the levels of HSF2 protein were analyzed upon exposure to hemin or TPA or to combined hemin and TPA treatment. In contrast to the increased accumulation of HSF2 protein in K562 cells exposed to hemin for 16 h, treatment with TPA resulted in a dramatic reduction of HSF2 protein by 4 h (41) and a complete loss by 16 -24 h (Fig. 1C) . However, a similar decrease in the levels of HSF2 protein was not detected in cells exposed to TPA for 1-6 h after a 16 h pretreatment with hemin (heϩTPA; Fig. 1C ). When K562 cells were preincubated with TPA for 1 to 4 h prior to addition of hemin for 16 h, the TPA-induced loss of HSF2 protein could not be reversed with hemin (TPAϩhe; Fig. 1C) . Together with previous studies (26, 27) , this provides evidence that the HSE binding activity induced by hemin (Fig. 1B) requires presence of HSF2. The amounts of Hsc70 remained constant on both hemin and TPA treatment.
To examine whether the hemin-induced increase and the TPA-induced decrease in HSF2 protein were due to changes in HSF2 mRNA expression, K562 cells were exposed to hemin or TPA for various time periods and poly(A) mRNA samples were analyzed by Northern blotting. In untreated cells, a basal HSF2 mRNA expression was detected, and the levels of HSF2 mRNA gradually increased up to sixfold by 24 h of hemin treatment ( Fig. 2A) . The amounts of hsp70, TRX, and ␤-actin mRNAs were analyzed in comparison with HSF2 mRNA in the same samples. Consistent with our previous results (28), hsp70 mRNA was also induced by hemin treatment, but, in contrast to HSF2 mRNA, hsp70 mRNA expression reached the maximum level already at 16 h and started to decrease thereafter ( Fig. 2A) . mRNA expression of human TRX, another gene that has been shown to be regulated in concert with HSF2 activation (28), was increased by hemin with kinetics similar to HSF2 mRNA ( Fig. 2A) . ␤-Actin was used to confirm the equal loading of mRNA samples. In contrast to the results obtained with hemin, upon exposure to TPA, HSF2 mRNA expression was gradually down-regulated after 6 h of TPA treatment to the extent that the HSF2 mRNA levels were decreased to 40% from the levels detected in untreated cells, as normalized against GAPDH mRNA levels; HSF2 mRNA levels were barely detectable at 24 -48 h of TPA treatment (Fig. 2B) .
HSF2 gene expression is regulated both at the transcriptional level and by mRNA stabilization in hemin-treated K562 cells
Next we wanted to establish whether the induction of HSF2 expression on hemin treatment was regulated on the transcriptional level; nuclear run-on assay was performed with nuclei isolated from untreated, heatshocked, and hemin-treated K562 cells. Transcription analysis revealed a modest but consistent 1.5-to 2-fold increase in HSF2 gene transcription upon exposure to hemin for 16 h (Fig. 3A) , as normalized against ␤-actin transcription. As expected, in contrast to transcriptional induction of the classical heat shock genes hsp70 and hsp90 in response to hemin and heat shock, transcription of the HSF2 gene was not induced by heat shock (Fig. 3A) . This is consistent with the finding that HSF2 DNA binding is activated in hemin-treated but not in heat-shocked K562 cells (26) . It is worth noting that the transcriptional induction of HSF2 gene was not detected in the earlier study (42) . This discrepancy may be due to the differences in experimental conditions, because a whole plasmid containing the mouse HSF2 cDNA was used earlier as a probe instead of the more specific human HSF2 cDNA insert used in the present study (for details, see Materials and Methods).
Because the prominently elevated HSF2 steadystate mRNA levels on hemin treatment ( Fig. 2A) were unlikely due to the modest, at most twofold transcriptional induction (Fig. 3A) , we wanted to determine whether the half-life of HSF2 mRNA was affected by hemin. To prevent de novo gene transcription, actinomycin D was added to control, hemin-treated, or heat-shocked cells for different time periods, and the HSF2 mRNA levels were monitored over the ensuing 4 h period. TRX mRNA was used as a normalization control in the quantitative analysis, since the half-life of TRX mRNA was not affected by hemin (Fig. 3B, C) . Exposure to hemin led to a marked stabilization of HSF2 mRNA. After 4 h of actinomycin D treatment, the relative level of HSF2 mRNA in hemintreated cells was clearly higher than in control cells when the values were normalized against TRX mRNA (Fig. 3B, C) . The half-life of HSF2 mRNA was less than 1 h in heat-shocked cells, whereas it was ϳ2 h in control cells. We also analyzed the half-life of hsp70 mRNA in control, hemin-treated, and heat-shocked cells. As shown in Fig. 3B , the half-life of hsp70 mRNA was ϳ2 h in control cells and 4 h in hemin-treated and heat-shocked cells, which is in agreement with earlier studies (43, 44) . To examine whether the stabilization of HSF2 mRNA required novel protein synthesis, K562 cells were incubated in the presence of cycloheximide, Figure 3 . Induction of HSF2 gene transcription and stabilization of HSF2 mRNA in K562 cells undergoing erythroid differentiation. A) Transcription rates of HSF2, hsp70, hsp90, and ␤-actin genes were analyzed by nuclear run-on assay. Equal number of nuclei from control (C), heat-shocked (HS; 1 h at 42°C), and hemintreated (he; 30 M for 6 and 16 h) K562 cells were used for in vitro labeling of newly synthesized transcripts that were hybridized to immobilized DNA probes. Hsp70 and hsp90 were used as positive controls for heat shock and hemin inducibility, and ␤-actin was used as an internal control for equal loading of samples. BS indicates plasmid Bluescript. Note the longer exposure time for the HSF2 blot. B) After treatment of K562 cells with hemin (30 M for 16 h) or heat shock (HS; 1 h at 42°C), treated and control cells were incubated with actinomycin D (actD; 6.4 g/ml) for 1, 2, 3, 4, and 6 h. Poly(A) mRNA was isolated and analyzed by Northern blotting using 32 P-labeled cDNA probes for HSF2, hsp70, and TRX. The mRNA sizes are indicated on the right. C) The intensities of radioactive signals were quantitated using a phosphorimaging scanner and the values obtained for HSF2 mRNA were normalized against the respective values for TRX mRNA, the half-life of which was not affected by hemin treatment.
an inhibitor of protein synthesis, either alone or in combination with hemin, and poly(A) mRNA levels were analyzed. However, no marked changes in the HSF2 mRNA levels were observed during cycloheximide treatment (data not shown), suggesting that the stabilization of HSF2 mRNA is not dependent on de novo protein synthesis. However, the amounts of HSF2 protein gradually decreased on cycloheximide treatment (data not shown), which is consistent with the study recently reported by Mathew and co-workers (29) .
Down-regulation of HSF2 mRNA by TPA requires the presence of HSF2 promoter
The decrease in HSF2 mRNA expression by TPA (Fig. 2B ) prompted us to investigate whether this down-regulation occurred at the promoter level. For this purpose, we made use of stably transfected K562 cell clones overexpressing either mouse HSF2-␣ (2␣-C7) or HSF2-␤ (2␤-D5) isoforms under the control of human ␤-actin promoter (27) . Consistent with earlier results, hemin-induced accumulation of both the endogenous and exogenous HSF2 protein was observed in 2␣-C7 cells, but not in 2␤-D5 cells ( Fig. 4;  ref 27 ). As expected, in K562 cells as well as in the transfected cell clones, the endogenous human HSF2 protein decreased during TPA treatment (Fig.  4) . In contrast, the exogenous mouse HSF2 isoforms expressed under the control of human ␤-actin promoter were not affected by TPA treatment (Fig. 4) , indicating that the inhibiting effect of TPA on HSF2 expression is likely to be mediated through the endogenous HSF2 promoter.
The differentiation lineage-dependent expression of HSF2 upon treatment with hemin or TPA is specific for K562 cells Finally, we wanted to determine the specificity of the differentiation pathway-dependent expression of HSF2. To this end, in addition to K562 cells, various human cell lines, such as Raji (Burkitt's lymphoma), Molt-4 (T-lymphoblastic leukemia), and HeLa (cervical carcinoma) cells, were treated with either hemin or TPA for 24 h and whole-cell extracts were analyzed by Western blotting. As shown in Fig. 5 , in all cell lines tested, HSF2 protein was readily detectable also in samples isolated from untreated cells. Yet the amounts of HSF2 varied considerably between different cell lines, Raji cells containing the highest and HeLa cells the lowest levels. A prominent hemininduced increase in HSF2 protein was observed only in K562 cells. Similarly, the TPA-mediated loss of HSF2 protein was specific for K562 cells induced to differentiate along the megakaryocytic lineage, since in the other cell lines there was essentially no change in the amounts of HSF2 protein (Fig. 5 ). Hsc70 protein levels are shown as a control for equal loading of samples.
DISCUSSION
We have shown that HSF2 protein levels increase in concert with acquisition of DNA binding activity during hemin-induced erythroid differentiation of human K562 cells (27, 42) . In this study, we have analyzed the molecular levels at which the regulation . Down-regulation of HSF2 mRNA expression on TPA treatment is mediated through the HSF2 promoter. Whole-cell extracts (12 g) from control (C), hemin-treated (he; 30 M for 24 h), and TPA-treated (T; 10 nM for 24 h) K562 cells as well as K562 cells stably overexpressing either mouse HSF2-␣ (2␣-C7) or mouse HSF2-␤ (2␤-D5) isoforms under the control of human ␤-actin promoter (27) were analyzed on an 8% SDS-PAGE and immunoblotted using antibodies against HSF2, Hsp70, and Hsc70. Note that the exogenous mouse HSF2 isoforms (mHSF2-␣ and mHSF2-␤) migrate slightly faster on an SDS-PAGE than the endogenous human HSF2 isoforms (the upper double band, see legend to Fig. 1C) , and can therefore be separated from the slower migrating human HSF2 counterparts.
of HSF2 expression occurs in K562 cells induced to differentiate along the erythroid or megakaryocytic lineage. Our results reveal that in hemin-treated K562 cells, HSF2 expression is up-regulated both at the transcriptional level and by mRNA stabilization. The enhanced expression of HSF2 is strictly specific for the erythroid properties of K562 cells; during TPA-induced megakaryocytic differentiation, HSF2 expression is efficiently and rapidly down-regulated, leading to a complete loss of HSF2 protein.
The K562 erythroleukemia cell line provides a unique human cell model with which to study gene expression during hematopoiesis. In vivo, the proliferation and maturation of megakaryocyte and erythroid precursors are regulated by two structurally related growth factors, thrombopoietin and erythropoietin, respectively (for review, see ref 45) . K562 cells possess several erythroid properties that are enhanced upon treatment with hemin (3, 46 -48) , whereas treatment with TPA leads to loss of their erythroid characteristics, directing these cells toward megakaryocytic lineage (49) . We show here that the expression of HSF2 is differentially regulated in K562 cells undergoing either erythroid or megakaryocytic differentiation. HSF2 seems to be needed for maintaining and enhancing the erythroid properties of K562 cells, as characterized by measuring globin expression (27) , whereas HSF2 is rapidly and efficiently down-regulated during TPAmediated differentiation along the megakaryocytic lineage. Identification and characterization of specific markers for the distinct hematopoietic lineages are important for understanding the molecular mechanisms that underlie the differentiation processes and malignant transformation. Recently, differential expression of the Kell blood group and CD10 antigens, two related membrane metallopeptidases, was reported in K562 cells undergoing megakaryocytic and erythroid differentiation (50) . Expression of Kell and CD10 antigens represent relatively late differentiation markers, whereas expression of HSF2 is up-regulated and down-regulated within a few hours in the presence of hemin and TPA, respectively. Furthermore, the differential regulation of HSF2 seems to be specific for the progenitor cell-like ability of K562 cells to differentiate along several lineages, since in Raji, Molt-4, and HeLa cells the levels of HSF2 protein did not essentially change when treated with hemin or TPA. Therefore, HSF2 expression could provide an early hallmark for lineage-specific differentiation pathways of K562 cells.
Although HSF2 is present in various cell types and tissues (22, 31) , it is to our knowledge the first transcription factor described whose expression is strictly regulated in K562 cells differentiating along the erythroid and megakaryocytic lineages. The importance of HSF2 for maintaining and promoting erythroid properties is further emphasized by the absence of this factor in K562 cells undergoing megakaryocytic differentiation. It is well established that certain hematopoietic-restricted transcription factors, such as GATA-1 and NF-E2, are coexpressed within the erythroid and megakaryocytic differentiation lineages, raising the possibility of common programs or mechanisms of gene activation in the various differentiation pathways (51) (52) (53) . GATA-1 was originally identified through its interaction within the ␤-globin locus control region (54, 55) . Subsequently, a consensus DNA binding motif for GATA-1 has been found in the cis-regulatory elements of virtually all known erythroid-expressed gene promoters (for review, see ref 56) . In K562 cells, the hemin-induced in vivo binding of HSF2 to the HSEs within the human hsp70 promoter results in transcriptional induction of the hsp70 gene (26, 42) . However, it is evident that HSF2 might have other target genes apart from the known heat shock genes (22, 28) . We speculate that during erythroid differentiation of K562 cells, in addition to or instead of activating the classical heat shock genes, HSF2 might be a potential candidate either alone or in combination with certain erythroidspecific transcription factor(s) to regulate the expression of erythroid-specific genes. In contrast, during differentiation along the megakaryocytic lineage, HSF2 seems to be dispensable, and its expression is downregulated.
The inducible expression of HSF2 indicates a different regulatory mechanism as compared with the stressresponsive transcription factor HSF1. Upon activation, expression of the HSF1 gene appears to remain unaltered but the HSF1 protein undergoes posttranslational modifications such as oligomerization (i.e., trimerization) and hyperphosphorylation (34, 57) . Although HSF2 is known to be converted from an inert dimeric state to an active trimer, the activation process is accompanied by enhanced accumulation of HSF2 protein (42) . In this study, the transcriptional induction of HSF2 in hemin-treated K562 cells was found to be 1.5-to 2-fold, and the stability of HSF2 mRNA was markedly increased in the presence of hemin, in contrast to the rapid decay of HSF2 mRNA in untreated and heat-shocked cells. In general, although the mechanisms underlying mRNA stabilization are not yet well understood, at least certain conserved features affecting the mRNA half-lives, such as sequence determinants and trans-acting regulatory factors, have been characterized (for review, see ref 58) . By using cycloheximide to inhibit protein synthesis, we show that the stabilization of HSF2 mRNA by hemin does not involve novel synthesis of an HSF2 mRNA binding protein.
Whether the half-life of HSF2 mRNA is regulated by stable RNA-interacting protein(s) remains to be elucidated. However, it was found that in the presence of cycloheximide, the levels of HSF2 protein rapidly de-creased, suggesting that the hemin-mediated increase in HSF2 protein during erythroid differentiation could be due to a stabilizing effect of hemin on some yet unknown HSF2-interacting protein(s). The short halflife of HSF2 protein might serve an important regulatory function considering the need for rapid downregulation of HSF2 during the megakaryocytic differentiation.
In conclusion, HSF2 provides an example of transcription factors, the expression of which is strictly regulated at multiple levels in a differentiation lineage-specific manner. In light of our study, regulation of HSF2 expression could be one of the key determinants in the commitment of K562 cells to either erythroid or megakaryocytic pathway of differentiation. The processes actually governing cell differentiation in vivo are certainly more complex, and only spatially and temporarily organized combinations of various components can ensure normal hematopoietic development.
